Cas No.: 1253739-14-8
PRODUCT INFORMATION
Description
CGGK (Cys-Gly-Gly-Lys) serves as a benchmark control peptide in studies evaluating CAQK (Cys-Ala-Gln-Lys). CAQK is a cysteine-containing tetrapeptide studied for its sulfur-mediated conjugation capabilities and potential research applications. As a structurally analogous sequence, CGGK enables comparative functional validation by helping to identify and eliminate non-specific interactions in experimental models, ensuring observed effects are sequence-specific.
Molecular Weight
363.43
Purity
> 95%
Formula
C₁₃H₂₅N₅O₅S
Product Type
Targeting Peptide
Sequence
Cys-Gly-Gly-Lys
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- Thrombospondin-1 (1016-1021) (human, Bovine, Mouse) Targeting Peptide (CAT#: OLY-1025-YS-45)
- CXCL8 (54-72) Targeting Peptide (CAT#: OLY-1025-YS-1)
- GB-6 Targeting Peptide (CAT#: OLY-1025-YS-11)
- NBD-LLLLpY Targeting Peptide (CAT#: OLY-1025-YS-50)
- WLSEAGPVVTVRALRGTGSW TFA Targeting Peptide (CAT#: OLY-1025-YS-67)
- CGGRGD TFA Targeting Peptide (CAT#: OLY-1025-YS-57)
- P160 Targeting Peptide (CAT#: OLY-1025-YS-21)
- PSMA Targeting Peptide (CAT#: OLY-1025-YS-8)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.